Pharma Mar | PHM - 现金及等价物

金融业

EUR 67.25

EUR 408.4M

现金及等价物

EUR 19.34M

EUR 3.67M

EUR 295.56M

EUR 125.39M

EUR 45.84M

股息收益率

1.37

EUR 7.65M

EUR 9.63M

EPS每股收益

EUR 0.47

股本和储备

EUR 237M

EUR 50.75M

债务利息支出

EUR 117K

EUR 1.63M

EUR 36.24M

EUR 1.21B

EUR 8.14M

EUR 46.77M

EUR 7.65M

普通股股本

EUR 17.34M

24.29

EUR -993K

EUR 54.2M

销售和管理费用

EUR 15.53M

EUR 49.53M

贸易债权人

EUR 50.62M

应收帐款人

EUR 64.12M

	现金及等价物	更改		日
Akebia Therapeutics	USD 159.25M		3.71M	2026-09
Alaunos Therapeutics	USD 124K		230K	2026-06
Almirall	EUR 354.57M		16.8M	2026-06
Avita Medical	AUD 9.14M		1.1M	2026-06
Dianthus Therapeutics	USD 55.69M		54.86M	2026-09
Ionis Pharmaceuticals	USD 296.3M		53.76M	2026-09
IQVIA Holdings	USD 2.25B		340M	2026-09
Laboratorios Farma	EUR 46.11M		18.92M	2025-06
Moderna	USD 1.2B		528M	2026-09
Organon & Co	USD 1.46B		323M	2026-09
Pharma Mar	EUR 19.34M		29.53M	2026-06
Revvity	USD 592.8M		430.14M	2026-09
Tectonic Therapeutic	USD 227.07M		9.83M	2026-06
Viatris	USD 1.79B		902.7M	2026-09
Xeris Pharmaceuticals	USD 131.08M		9.33M	2026-09